Hims & Hers Health, Inc. – NYSE:HIMS
Founder-led company
Hims & Hers Health stock price today
$41.822
+15.26
+57.46%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 1 hour
Hims & Hers Health stock price monthly change
+22.28%
month
Hims & Hers Health stock price quarterly change
+22.28%
quarter
Hims & Hers Health stock price yearly change
+197.76%
year
Hims & Hers Health key metrics
Market Cap | 5.56B |
Enterprise value | 1.92B |
P/E | -28.94 |
EV/Sales | 3.65 |
EV/EBITDA | -33.09 |
Price/Sales | 3.73 |
Price/Book | 6.31 |
PEG ratio | -0.64 |
EPS | -0.01 |
Revenue | 959.40M |
EBITDA | -6.21M |
Income | -2.35M |
Revenue Q/Q | 45.81% |
Revenue Y/Y | 55.65% |
Profit margin | -12.46% |
Oper. margin | -13.04% |
Gross margin | 77.57% |
EBIT margin | -13.04% |
EBITDA margin | -0.65% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHims & Hers Health stock price history
Hims & Hers Health stock forecast
Hims & Hers Health financial statements
Average Price Target
$24.89
Potential downside: -40.48%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 207.91M | -7.15M | -3.44% |
|---|---|---|---|
| Sep 2023 | 226.69M | -7.56M | -3.34% |
| Dec 2023 | 246.61M | 1.24M | 0.5% |
| Mar 2024 | 278.17M | 11.12M | 4% |
| 2024-02-26 | 0.004 | 0.01 |
|---|
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | 0.34% |
| 2021 | |
| 2022 | |
| 2023 |
| Jun 2023 | 389884000 | 69.81M | 17.91% |
|---|---|---|---|
| Sep 2023 | 413865000 | 85.30M | 20.61% |
| Dec 2023 | 441186000 | 97.15M | 22.02% |
| Mar 2024 | 448106000 | 103.62M | 23.12% |
| Jun 2023 | 16.82M | 2.37M | -2.54M |
|---|---|---|---|
| Sep 2023 | 25.19M | -31.06M | -1.55M |
| Dec 2023 | 23.91M | 20.69M | -5.89M |
| Mar 2024 | 25.83M | 13.04M | -30.30M |
Hims & Hers Health alternative data
What is mobile apps rank?
Category:
| Aug 2023 | 14 |
|---|---|
| Sep 2023 | 15 |
| Oct 2023 | 12 |
| Nov 2023 | 14 |
| Dec 2023 | 8 |
| Jan 2024 | 15 |
| Feb 2024 | 15 |
| Mar 2024 | 11 |
| Apr 2024 | 12 |
| May 2024 | 13 |
| Jun 2024 | 7 |
| Jul 2024 | 13 |
| Aug 2024 | 13 |
| Sep 2024 | 6 |
| Oct 2024 | 16 |
| Nov 2024 | 16 |
| Dec 2024 | 9 |
Hims & Hers Health Social Media Accounts
What are followers?
+1.05%
month
| May 2025 | 218146 |
|---|---|
| Jul 2025 | 223065 |
| Aug 2025 | 225402 |
What is job openings count?
| Sep 2023 | 109 |
|---|---|
| Oct 2023 | 78 |
| Nov 2023 | 99 |
| Dec 2023 | 83 |
| Jan 2025 | 97 |
| Feb 2025 | 94 |
| May 2025 | 84 |
| Jul 2025 | 94 |
| Aug 2025 | 103 |
| Sep 2023 | 651 |
|---|---|
| Oct 2023 | 651 |
| Nov 2023 | 651 |
| Dec 2023 | 651 |
| Jan 2024 | 651 |
| Feb 2024 | 651 |
| Mar 2024 | 1,046 |
| Apr 2024 | 1,046 |
| May 2024 | 1,046 |
| Jun 2024 | 1,046 |
| Jul 2024 | 1,046 |
Hims & Hers Health other data
54.51%
+0.49%
of HIMS is owned by hedge funds
138
+2
111.17M
+1.66M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 84142 |
| Apr 2024 | 0 | 376094 |
| May 2024 | 110000 | 964324 |
| Jun 2024 | 0 | 1026428 |
| Oct 2024 | 0 | 779474 |
| Nov 2024 | 5000 | 735937 |
| Dec 2024 | 0 | 128387 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CHI MICHAEL officer: Chief Commercial Officer | Class A Common Stock | 7,259 | $32.25 | $234,103 | ||
Option | CHI MICHAEL officer: Chief Commercial Officer | Stock Option (right to buy) | 7,259 | $6.82 | $49,506 | ||
Option | BAIRD MELISSA officer: Chief Op.. | Class A Common Stock | 85,561 | $0.4 | $34,224 | ||
Sale | BAIRD MELISSA officer: Chief Op.. | Class A Common Stock | 26,266 | $30.55 | $802,505 | ||
Option | BAIRD MELISSA officer: Chief Op.. | Stock Option (right to buy) | 85,561 | $0.4 | $34,224 | ||
Option | CHI MICHAEL officer: Chief Commercial Officer | Class A Common Stock | 7,259 | $6.82 | $49,506 | ||
Sale | BAIRD MELISSA officer: Chief Op.. | Class A Common Stock | 51,082 | $31.09 | $1,587,986 | ||
Sale | BAIRD MELISSA officer: Chief Op.. | Class A Common Stock | 8,213 | $31.98 | $262,635 | ||
Option | CHI MICHAEL officer: Chief Commercial Officer | Class A Common Stock | 2,054 | $11.53 | $23,683 | ||
Sale | CHI MICHAEL officer: Chief Commercial Officer | Class A Common Stock | 2,054 | $33.56 | $68,932 |
| Quarter | Transcript |
|---|---|
| Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 26 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Andrew Dudum (1989) Co-Founder, Director & Chief Executive Officer | $627,390 |
| Mr. Spencer Lee (1979) Consultant | $537,600 |
| Ms. Melissa Baird (1978) Chief Operations Officer | $535,570 |
Hims & Hers Health's Transformation Into A Precision Health Platform
Hims & Hers: From Telehealth To Wellness Hub, The Bright Future
Hims & Hers: Still Growing After Breakup With Novo Nordisk
Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade)
Hims & Hers Health: What's Wall Street Missing In This Weight-Loss Stock?
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
How Hims & Hers Health Is Quietly Changing Healthcare
Why Hims & Hers Management Might Be Its Most Valuable Asset
Novo Nordisk: The Market Doesn't Get It
-
What's the price of Hims & Hers Health stock today?
One share of Hims & Hers Health stock can currently be purchased for approximately $41.82.
-
When is Hims & Hers Health's next earnings date?
Unfortunately, Hims & Hers Health's (HIMS) next earnings date is currently unknown.
-
Does Hims & Hers Health pay dividends?
No, Hims & Hers Health does not pay dividends.
-
How much money does Hims & Hers Health make?
Hims & Hers Health has a market capitalization of 5.56B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 65.49% to 872M US dollars. Hims & Hers Health made a loss 23.55M US dollars in net income (profit) last year or $0.01 on an earnings per share basis.
-
What is Hims & Hers Health's stock symbol?
Hims & Hers Health, Inc. is traded on the NYSE under the ticker symbol "HIMS".
-
What is Hims & Hers Health's primary industry?
Company operates in the Consumer Defensive sector and Household & Personal Products industry.
-
How do i buy shares of Hims & Hers Health?
Shares of Hims & Hers Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Hims & Hers Health's key executives?
Hims & Hers Health's management team includes the following people:
- Mr. Andrew Dudum Co-Founder, Director & Chief Executive Officer(age: 36, pay: $627,390)
- Mr. Spencer Lee Consultant(age: 46, pay: $537,600)
- Ms. Melissa Baird Chief Operations Officer(age: 47, pay: $535,570)
-
Is Hims & Hers Health founder-led company?
Yes, Hims & Hers Health is a company led by its founder Mr. Andrew Dudum.
-
How many employees does Hims & Hers Health have?
As Jul 2024, Hims & Hers Health employs 1,046 workers.
-
When Hims & Hers Health went public?
Hims & Hers Health, Inc. is publicly traded company for more then 6 years since IPO on 13 Sep 2019.
-
What is Hims & Hers Health's official website?
The official website for Hims & Hers Health is forhims.com.
-
Where are Hims & Hers Health's headquarters?
Hims & Hers Health is headquartered at 2269 Chestnut Street, San Francisco, CA.
-
How can i contact Hims & Hers Health?
Hims & Hers Health's mailing address is 2269 Chestnut Street, San Francisco, CA and company can be reached via phone at +41 58510195.
-
What is Hims & Hers Health stock forecast & price target?
Based on 8 Wall Street analysts` predicted price targets for Hims & Hers Health in the last 12 months, the avarage price target is $24.89. The average price target represents a -40.48% change from the last price of $41.82.
Hims & Hers Health company profile:
Hims & Hers Health, Inc.
forhims.comExchange:
NYSE
Full time employees:
1,046
Industry:
Household & Personal Products
Sector:
Consumer Defensive
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
2269 Chestnut Street
San Francisco, CA 94123
San Francisco, CA 94123
CIK: 0001773751
ISIN: US4330001060
CUSIP: 433000106
